RecruitingEarly Phase 1NCT05700617
Cardiac Power Output in Cardiogenic Shock Patients
Myocardial Reserve in Advanced Heart Failure Patients
Sponsor
University of Chicago
Enrollment
5 participants
Start Date
Jul 6, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study examines whether cardiac power output — a measurement taken during a right heart catheterization (a procedure where a thin tube is inserted into the heart's right side to measure blood flow and pressure) — can better predict outcomes in patients with severely weakened hearts who may need advanced treatments.
**You may be eligible if...**
- You are 18 or older with a reduced ejection fraction (heart pumping ability of 40% or less)
- You are referred for right heart catheterization to evaluate whether you need advanced therapies like a heart pump, transplant, or IV heart medications
- Your kidney function is adequate (eGFR ≥ 30 mL/min)
**You may NOT be eligible if...**
- You have very poor kidney function (eGFR below 30)
- You have severe complications that make the procedure unsafe
- You are not expected to be admitted to the hospital based on the catheterization results
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUG1:1 Randomization to receive milrinone
Randomized to receive either inotropic agent: milrinone or no agent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05700617
Related Trials
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288653 locations
Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker
NCT075631531 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370638 locations
The Salt Study for Heart Failure
NCT075605921 location
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
NCT06991257135 locations